Adriano Favero

Mr. Adriano Favero


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2025 in REVISTA FOCO
Verified
Journal Article
Open access
PDF file
TOTayná Eloise Lopes de Oliveira
Tayná Eloise Lopes de Oliveira
PFPaulo Henrique Figueiredo
Paulo Henrique Figueiredo
LMLuan Carlos Machado
Luan Carlos Machado
AFAdriano Favero
Adriano Favero
WFWagner Luiz da Costa Freitas
Wagner Luiz da Costa Freitas
FFFagner Luiz Da Costa Freitas
Fagner Luiz Da Costa Freitas
Os fitoterápicos tem sido usados empiricamente a séculos, porem, nos últimos anos a busca por compostos extraídos de plantas tem se intensificado. As plantas possuem seus metabólitos secundários atuando como um sistema de defesa e destes podem ser extraídos como óleos essenciais, frequentemente exibindo capacidades antimicrobianas. O presente estudo realizou o plantio, extração, análise da composição e rendimento do óleo essencial de Melaleuca alternifolia (OEM), alem de e avaliar sua capacidade antibacteriana pelos testes de disco-difusão, CIM e CBM. O OEM apresentou um rendimento de 1%, com 22 compostos químicos sendo terpinen-4-ol, α-terpineno e γ-terpineno os majoritários representando 73,43% da concentração total. O teste antimicrobiano mostrou um amplo espectro de ação sendo eficaz em todas as estirpes testadas. O estudo concluiu que o OEM, após futuras pesquisas, pode ser uma importante ferramenta no combate a microrganismos, principalmente resistentes aos antimicrobianos comerciais.

25 August 2021 in Revista de Patologia Tropical / Journal of Tropical Pathology
Verified
Journal Article
Open access
PDF file
AFAdriano Favero
Adriano Favero
VPVanessa Arantes Pinto
Vanessa Arantes Pinto
GAGabriela Santos Alencar
Gabriela Santos Alencar
ABAmanda Knorst Bellon
Amanda Knorst Bellon
APAlexandra Lays Petry
Alexandra Lays Petry
FFFagner Luiz Da Costa Freitas
Fagner Luiz Da Costa Freitas
This cross-sectional study evaluates the presence of antibodies against Neospora caninum and Toxoplasma gondii in cattle raised in Realeza, PR. There was a seroprevalence of N. caninum and T. gondii of 87.5% and 67.9%, respectively in the properties assessed. The frequencies of T. gondii and N. caninum in the animals were 41.1% and 55.1%, respectively. The studied coccidia are widely distributed in dairy cows reared on family farms in the municipality of Realeza, PR. Sanitary control for reproductive diseases must be adopted to prevent miscarriages and the economic damage caused by the disease. Future studies should be performed to investigate how widespread these pathogens are in cattle herds in southwestern Parana. KEYWORDS: Toxoplasmosis; neosporosis; Neospora caninum; Toxoplasma gondii; serology, Bos taurus.

15 October 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
BSBruna Simioni
Bruna Simioni
PRPaula Maria Carneiro Rocha
Paula Maria Carneiro Rocha
AFAdriano Favero
Adriano Favero
JSJosé Luis da Conceição Silva
José Luis da Conceição Silva
RGRinaldo F. Gandra Gandra
Rinaldo F. Gandra Gandra
Rita de Cássia Garcia SimãoRita de Cássia Garcia Simão
Rita de Cássia Garcia Simão
The present study investigated the impact of genetic engineering strategies to produce a cell-free xylanase for applications in the baking industry. The xynA1 gene from the nonpathogenic bacterium Caulobacter vibrioides was integrated into the pAS22 vector with a xylose-inducible promoter and introduced back into the bacteria, resulting in the creation of the BS-xynA1. This construct exhibited substantial secreted xylanase 1 (XynA1) activity, reaching 17.22 U/mL, and a specific activity of 278.64 U/mg after an 18 h growth period with 0.3% (v/v) xylose plus 0.2% (w/v) corn straw. RT-qPCR analysis confirmed that higher xylanase activity in C. vibrioides cells was correlated with increased transcription of the xynA1 gene in the induction medium. Moreover, BS-xynA1 cells coexpress other enzymes, including xylanase 2 (XynA2), cellulase, pectinase, α-amylase, β-glucosidase, β-xylosidase, and α-L-arabinosidase, at low levels (≤2 U/mL). In vitro comparison of cell-free xylanases from BS-xynA1 with three commercially available xylanase-containing mixtures commonly utilized in baking protocols revealed its superior specific activity (163.4 U/mg) across a broad temperature range (30–100 °C), with optimal performance at 50 °C. In practical baking tests, the addition of cell-free XynA1 led to a reduction in dough kneading time and increase in bread height compared to those of the control. Notably, the incorporation of XynA1 resulted in enhanced alveolar structure formation within the bread crumb. Specifically, the following changes were observed in the mass parameters compared to those of the control: an increase in extensibility, elasticity, and deformation energy, and subsequent improvements in strength. Additionally, XynA1 addition led to a reduction in toughness and toughness/elasticity index, indicating a reduction in the mass stiffness of the enzyme-treated bread. To date, this is the first successful application of recombinant XynA1 from C. vibrioides in biotechnological processes related to baking, underscoring the potential and prospects in the food industry.

1 August 2025 in REVISTA FOCO
Verified
Journal Article
Open access
PDF file
AFAdriano Favero
Adriano Favero
VPVictor Mateus Praniewskir
Victor Mateus Praniewskir
PFPaulo Henrique Figueiredo
Paulo Henrique Figueiredo
JTJúlia Teodoro
Júlia Teodoro
WFWagner Luiz da Costa Freitas
Wagner Luiz da Costa Freitas
FFFagner Luiz da Costa Freitas
Fagner Luiz da Costa Freitas
Objective: Cultivation, extraction and investigation of the chemical composition, antimicrobial activity of essential oils (EOs) of Cymbopogon winterianus (CEO) and Melaleuca alternifolia (TTO); correlating with antimicrobials Amoxicillin + Clavulanic Acid. 30mcg , Ciprofloxacin 5Mcg and Clotrimazole 50μg. Materials and Methods: The cultivation was carried out in southwestern Paraná/Brazil, extraction was performed by steam distillation and chemical characterization by gas chromatography . For antimicrobial susceptibility, the 10 Gram-positive strains, 10 Gram-negative strains and 5 yeasts were standardized (1.5 x108 CFU/mL) for disk diffusion assay of EOs and antimicrobials. Results: Chromatographic analysis revealed that the main components of CEO are citronellal (51.46%), geraniol (13.36%) and citronellol (9.36%), and of TTO are terpinen-4-ol (26.91%), α-terpinene (24.71%) and γ-terpinene (21.81%). Antimicrobial susceptibility testing showed that both EOs have a broad spectrum of action against Gram-positive and Gram-negative bacteria and yeasts. CEO demonstrated activity against all bacteria tested, presenting similar or superior activity to commercial antimicrobials in 9 strains of bacteria and 4 yeasts, while TTO was effective against all strains tested, with similar or superior activity to antimicrobials in 5 strains of bacteria and all yeasts. The antimicrobial action is attributed to the synergistic action of the compounds, disrupting and permeabilizing the cell membrane of microorganisms, inhibiting enzymatic activities or causing leakage of essential ions. Conclusion: The results indicate that the EOs tested are promising natural antimicrobials, which can be used as alternatives or complements to traditional antibiotics, especially in cases of bacterial resistance.

28 October 2025 in Arquivos de Ciências da Saúde da UNIPAR
Verified
Journal Article
Open access
PDF file
GDGabriel Eduardo Dresch
Gabriel Eduardo Dresch
LMLuana Thaise de Miranda
Luana Thaise de Miranda
MDMateus Foltz Delabeneta
Mateus Foltz Delabeneta
MTMaurício Turkiewicz
Maurício Turkiewicz
Rita de Cássia Garcia SimãoRita de Cássia Garcia Simão
Rita de Cássia Garcia Simão
JPJacqueline Plewka
Jacqueline Plewka
Os indicadores do monitoramento interno da qualidade (MIQ), demonstram a qualidade dos exames citopatológicos do colo do útero dos laboratórios que prestam serviço ao Sistema Único de Saúde (SUS), pela análise e acompanhamento desses indicadores. O objetivo deste trabalho foi avaliar o desempenho dos laboratórios prestadores que realizaram os exames citopatológicos do colo do útero no SUS no Brasil, unidades federativas e regiões, através do MIQ estabelecidos pelo Ministério da Saúde. Trata-se de um estudo retrospectivo, quantitativo dos dados obtidos no departamento de informática do sistema único de saúde referente aos resultados citopatológicos emitidos pelos laboratórios brasileiros, no período de 2014 a 2023 utilizados na tabulação dos indicadores do MIQ. Os resultados mostraram que foram realizados 59.306.209 exames citopatológicos no Brasil, sendo 98,8% satisfatórios para análise oncótica. Os indicadores do MIQ evidenciam que o índice de positividade, estava abaixo do esperado, 2,9%, o que sugere que alterações celulares podem não estar sendo identificadas. Nos indicadores com células escamosas atípicas entre os exames alterados, alguns estavam acima do parâmetro, como Piauí (73,2%) e Distrito Federal (70,1%), assim como razão células escamosas atípicas e lesões intraepiteliais escamosas, os quais impactam no percentual do índice de positividade. No percentual de exames compatíveis com lesão intraepitelial escamosa de alto grau dentre exames satisfatórios, 55,6% dos estados brasileiros estavam abaixo do recomendado. Como alguns indicadores do MIQ apresentaram valores abaixo dos parâmetros recomendados, isso pode comprometer a efetividade do programa de rastreamento do câncer de colo de útero.

1 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
BSBruna Simioni
Bruna Simioni
PRPaula Maria Carneiro Rocha
Paula Maria Carneiro Rocha
AFAdriano Favero
Adriano Favero
JSJosé Luis da Conceição Silva
José Luis da Conceição Silva
RGRinaldo F. Gandra Gandra
Rinaldo F. Gandra Gandra
Rita de Cássia Garcia SimãoRita de Cássia Garcia Simão
Rita de Cássia Garcia Simão
This study investigated the impact of using genetic engineering strategies and a cell-free Xylanase in the baking industry. The xynA1 gene from the nonpathogenic bacterium Caulobacter crescentus (C. crescentus) (NA1000 strain) was integrated into the pAS22 vector with a xylose-inducible promoter and introduced back into the bacteria, resulting in the creation of the BS-xynA1. This construct exhibited substantial secreted xylanase activity, reaching 17.22 U/mL, and a specific activity of 278.64 U/mg after an 18-hour growth period with 0.2% (w/v) corn straw. RT-qPCR analysis confirmed that higher xylanase activity in C. crescentus cells was correlated with increased transcription of the xynA1 gene. Moreover, BS-xynA1 cells coexpress other enzymes , including cellulase, pectinase, α-amylase, β-glycosidase, β-xylosidase, and α-L-arabinosidase , at low levels (≤2 U/mL). In vitro comparison of cell-free xylanase from BS-xynA1 with three commercially available xylanase-containing mixtures commonly utilized in baking protocols revealed its superior specific activity (163.4 U/mg) across a broad temperature range (30-100 °C), with optimal performance at 50 °C. In practical baking tests, the addition of cell-free Xylanase I led to a 9% reduction in dough beat time and an impressive 18.2% increase in bread height compared to those of the control. Notably, the incorporation of Xylanase I resulted in enhanced alveolar structure formation within the bread crumb. Specifically, the following changes were observed in the mass parameters compared to those of the control: an 18.8% increase in extensibility, a 5.2% increase in elasticity, an 8.3% increase in deformation energy, and subsequent improvements in strength. Additionally, Xylanase I inclusion led to a 6.0% reduction in toughness and a 20.6% reduction in the toughness/elasticity index, indicating a reduction in the mass stiffness of the enzyme-treated bread. To date, this is the first successful application of recombinant xylanase I from C. crescentus in biotechnological processes related to baking, underscoring the potential and prospects of synthetic biology in the food industry.